Piping for GSK

Pharmaceutical group GlaxoSmithKline Biologicals has appointed Ensysta Pharma (International Division, Energy business line) to design-build the piping for Building WN 158, currently under construction at its Wavre site, which will be devoted to the industrialization of vaccine production.
Worth €12.7m, the works began in July 2011 and will take 18 months to complete.